EIKONOKLASTES THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 13 Nov 2025)
What this means for you
Not registered yet, but its 07 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97623383
- Mark type
- Stylized text
- Filed
- 07 Oct 2022
- Published for opposition
- 17 Oct 2023
- Attorney of record
- Kevin M. Bovard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations comprising small molecules and biologics being biopharmaceuticals, and biologically active substances being enzymes and microorganisms, all for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, hepatology, gynecology, rheumatology, and ophthalmologic disorders; pharmaceutical products being pharmaceutical preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, hepatology, gynecology, rheumatology, and ophthalmologic disorders; biopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; therapeutic products being therapeutic preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, hepatology, gynecology, rheumatology, and ophthalmologic disorders; diagnostic products, preparations and agents for medicinal purposes
Owner
- Eikonoklastes Therapeutics, Inc., Cincinnati, OH, US
- Eikonoklastes Therapeutics, Inc., Cincinnati, OH, US
Prosecution history
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 4 GRANTED
- 13 Nov 2025 — SOU EXTENSION 4 FILED
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 16 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2025 — SOU EXTENSION 3 GRANTED
- 15 May 2025 — SOU EXTENSION 3 FILED
- 15 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2024 — SOU EXTENSION 2 GRANTED
- 10 Dec 2024 — SOU EXTENSION 2 FILED
- 10 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2024 — SOU EXTENSION 1 GRANTED
- 10 Jun 2024 — SOU EXTENSION 1 FILED